Corrigendum to “distinct Mutational Features Across Preinvasive and Invasive Subtypes Identified Through Comprehensive Profiling of Surgically Resected Lung Adenocarcinoma” [modern Pathology. 2022;35(9):1181-1192]
Chan Xiang,Chunyu Ji,Yiran Cai,Haohua Teng,Yulu Wang,Ruiying Zhao,Zhanxian Shang,Lianying Guo,Shengnan Chen,Analyn Lizaso,Jing Lin,Haozhe Wang,Bing Li,Zhou Zhang,Jikai Zhao,Jinzhi Wei,Jiaxin Liu,Lei Zhu,Wentao Fang,Yuchen Han
DOI: https://doi.org/10.1016/j.modpat.2023.100407
IF: 8.209
2024-01-01
Modern Pathology
Abstract:The authors of the article entitled, “Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma” (Modern Pathology 2022;35(9):1181-1192; DOI: https://doi.org/10.1038/s41379-022-01076-w) have discovered an error in the published Acknowledgements statement related to the funding number of the National Natural Science Foundation of China by CX. The correct number should be as follows: 82003154. A corrected statement in full is included below. Corrected acknowledgements in full: The authors thank all the patients who participated in this study and their families. We also thank the investigators, study coordinators, operation staff, and the whole project team who worked on this study. This work was supported by grants from the Shanghai Municipal Health Commission Intelligent Medical Research Project (Grant no. 2018ZHYL0213 to YH); Clinical Research Project (Grant No. 20194Y0053 to CX); National Natural Science Foundation of China (Grant No. 82003154 to CX); and Shanghai Jiao Tong University Medical Engineering Cross Fund (Grant no. YG2019QNA50 to CX). The funders had no role in the study design, participant recruitment, data collection, data analysis, data interpretation, manuscript preparation, and the decision to submit the paper for publication. Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinomaModern PathologyVol. 35Issue 9PreviewLung adenocarcinoma (LUAD) is a heterogeneous disease. Our study aimed to understand the unique molecular features of preinvasive to invasive LUAD subtypes. We retrospectively analyzed the clinical, histopathological, and molecular data of 3,254 Chinese patients with preinvasive lesions (n = 252), minimally invasive adenocarcinomas (n = 479), and invasive LUAD (n = 2,523). Molecular data were elucidated using a targeted 68-gene next-generation sequencing panel. Our findings revealed four preinvasive lesion-predominant gene mutations, including MAP2K1 insertion-deletions (indels), BRAF non-V600E kinase mutations, and exon 20 insertions (20ins) in both EGFR and ERBB2, which we referred to as mutations enriched in AIS (MEA). Full-Text PDF Open Access